Overview

Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
To investigate the efficacy and safety of once daily enoxaparin as a "bridge" to warfarin for the outpatient treatment of acute deep venous thrombosis or pulmonary embolism.
Phase:
N/A
Details
Lead Sponsor:
Brigham and Women's Hospital
Collaborator:
Sanofi
Treatments:
Enoxaparin